{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:18:59Z","timestamp":1792685939282,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009116","name":"Harvard Transdisciplinary Research in Energetics and Cancer Center, Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtct.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:39:44Z","timestamp":1738928384000},"page":"265.e1-265.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relevance of Recent Thymic Emigrants Following Allogeneic Hematopoietic Cell Transplantation for Pediatric Patients with Inborn Errors of Immunity"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-7525","authenticated-orcid":false,"given":"Daniel","family":"Drozdov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini S.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-911X","authenticated-orcid":false,"given":"Christen L.","family":"Ebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtct.2025.02.003_bib0001","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.003_bib0002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-022-00800-6","article-title":"Gene therapy for inborn errors of immunity: past, present and future","volume":"23","author":"Fischer","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2025.02.003_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162605","article-title":"Personalized hematopoietic stem cell transplantation for inborn errors of immunity","volume":"14","author":"Slatter","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2025.02.003_bib0004","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/10428194.2016.1265113","article-title":"Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant","volume":"58","author":"Goldberg","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.003_bib0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcyt.2020.05.005","article-title":"Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"Van Roessel","year":"2020","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.003_bib0006","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2020007905","article-title":"CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation","volume":"137","author":"de Koning","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.003_bib0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cyto.b.21341","article-title":"Thymic output: assessment of CD4+ recent thymic emigrants and T-cell receptor excision circles in infants","volume":"92","author":"Ravkov","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.003_bib0008","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41409-018-0103-y","article-title":"Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation","volume":"53","author":"Duinhouwer","year":"2018","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2025.02.003_bib0009","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fped.2020.00454","article-title":"Immune monitoring after allogeneic hematopoietic cell transplantation: toward practical guidelines and standardization","volume":"8","author":"Boelens","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2025.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3389\/fimmu.2020.01341","article-title":"Evaluating thymic function after Human hematopoietic stem cell transplantation in the personalized medicine era","volume":"11","author":"Gaballa","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jtct.2025.02.003_bib0011","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/eji.200636976","article-title":"Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children","volume":"37","author":"Junge","year":"2007","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.02.003_bib0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1399-0039.2011.01820.x","article-title":"Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again","volume":"79","author":"Toubert","year":"2012","journal-title":"Tissue Antigens"},{"issue":"10","key":"10.1016\/j.jtct.2025.02.003_bib0013","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3324\/haematol.2012.072264","article-title":"T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC\/TREC ratio and thymic naive T cells","volume":"98","author":"Ringhoffer","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2025.02.003_bib0014","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2025.02.003_bib0015","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbmt.2019.06.018","article-title":"Use of multivariate immune reconstitution patterns to describe immune reconstitution after allogeneic stem cell transplantation in children","volume":"25","author":"Mellgren","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.02.003_bib0016","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers"},{"issue":"9915","key":"10.1016\/j.jtct.2025.02.003_bib0017","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jtct.2025.02.003_bib0018","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bbmt.2014.06.003","article-title":"Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein Deficiency\/X-linked lymphoproliferative Disease type 1","volume":"20","author":"Marsh","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.003_bib0019","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/bloodadvances.2020001748","article-title":"Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis","volume":"4","author":"Felber","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2025.02.003_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10875-020-00888-2","article-title":"Experience with a reduced toxicity allogeneic transplant regimen for non-CGD primary immune deficiencies requiring myeloablation","volume":"41","author":"Chandra","year":"2021","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2025.02.003_bib0021","doi-asserted-by":"crossref","first-page":"e30988","DOI":"10.1002\/pbc.30988","article-title":"Good engraftment after reduced intensity targeted busulfan-based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies","volume":"71","author":"Klink","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"10.1016\/j.jtct.2025.02.003_bib0022","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jtct.2025.02.003_bib0023","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.2021012431","article-title":"Nonclassical manifestations of acute GVHD","volume":"138","author":"Zeiser","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.02.003_bib0024","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1182\/blood.2019000487","article-title":"Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation","volume":"134","author":"Battipaglia","year":"2019","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jtct.2025.02.003_bib0025","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.003_bib0026","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/bloodadvances.2020004072","article-title":"T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity","volume":"6","author":"Lum","year":"2022","journal-title":"Blood Advances"},{"key":"10.1016\/j.jtct.2025.02.003_bib0027","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41409-022-01594-w","article-title":"Dynamics of recent thymic emigrants in pediatric recipients of allogeneic hematopoetic stem cell transplantation","volume":"57","author":"Drozdov","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.003_bib0028","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jcyt.2024.04.073","article-title":"Immune recovery and the role of recent thymic emigrated T lymphocytes after pediatric hematopoietic stem cell transplantation","volume":"26","author":"Justus","year":"2024","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jtct.2025.02.003_bib0029","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/j.jtct.2023.12.432","article-title":"Predictors for recent thymic emigrant T cell reconstitution after hematopoietic cell transplantation","volume":"30","author":"McAvoy","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"10.1016\/j.jtct.2025.02.003_bib0030","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.02.003_bib0031","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.bbmt.2020.07.013","article-title":"Early mixed lymphoid donor\/host chimerism is associated with improved transplant outcome in patients with primary or secondary myelofibrosis","volume":"26","author":"Deeg","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.003_bib0032","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/leu.2011.244","article-title":"Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation","volume":"26","author":"Breuer","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.003_bib0033","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e46","article-title":"Impact of day 14 peripheral blood chimerism after allogeneic hematopoietic stem cell bone transplantation on the treatment outcome of non-malignant disease","volume":"34","author":"Choi","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"11","key":"10.1016\/j.jtct.2025.02.003_bib0034","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.bbmt.2013.09.001","article-title":"An intermediate Alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"19","author":"Marsh","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.003_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2014.11.674","article-title":"Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus Alemtuzumab","volume":"21","author":"Willemsen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.003_bib0036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2015-07-659672","article-title":"Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT","volume":"127","author":"Marsh","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2025.02.003_bib0037","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2567.2009.03115.x","article-title":"Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model","volume":"128","author":"Hu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jtct.2025.02.003_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.crimmu.2022.03.001","article-title":"Loss of thymic function promotes EAE relapse in anti-CD52-treated mice","volume":"3","author":"Adegoke","year":"2022","journal-title":"Curr Res Immunol"},{"issue":"50","key":"10.1016\/j.jtct.2025.02.003_bib0039","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1073\/pnas.1313654110","article-title":"Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation","volume":"110","author":"Jones","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.003_bib0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.coph.2010.04.008","article-title":"Emerging strategies to boost thymic function","volume":"10","author":"Holl\u00e4nder","year":"2010","journal-title":"Curr Opin Pharmacol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:01:57Z","timestamp":1762639317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725010127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2666636725010127"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.003","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of Recent Thymic Emigrants Following Allogeneic Hematopoietic Cell Transplantation for Pediatric Patients with Inborn Errors of Immunity","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}